
|
Medicis Pharmaceutical Corporation. The Group's principal activities are developing and marketing products for the treatment of dermatological, aesthetic and podiatric conditions. The Group offers various products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, ... More
|
|
|
|
First Call expects 0.59 EPS for next quarter.
The current Price Target for MRX is $23.50.

| 23.81 Last |
---- Today’s Change |
-- Today’s Open |
-- Day High |
-- Day Low |
-- Volume |
| Quotes delayed by at least 20 minutes | |||||
MRX
IndustryMouse over chart for more details